Atrey Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.90 M
as on 06-07-2024
- Paid Up Capital ₹ 2.90 M
as on 06-07-2024
- Company Age 11 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.88 Cr
as on 06-07-2024
- Revenue -33.69%
(FY 2022)
- Profit -61.81%
(FY 2022)
- Ebitda 36.93%
(FY 2022)
- Net Worth 1.64%
(FY 2022)
- Total Assets -8.06%
(FY 2022)
About Atrey Pharmaceuticals
The Corporate was formerly known as Coscare India Private Limited. The Company is engaged in the Fmcg Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.90 M and a paid-up capital of Rs 2.90 M.
The company currently has active open charges totaling ₹2.88 Cr.
Minish Shah and Naman Shah serve as directors at the Company.
- CIN/LLPIN
U24100GJ2013PTC074736
- Company No.
074736
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Apr 2013
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Atrey Pharmaceuticals Private Limited offer?
Atrey Pharmaceuticals Private Limited offers a wide range of products and services, including Cosmetics, Hair & Beauty Products, Beauty Cosmetics, Ayurvedic,Herbal Products & Medicine, Ayurvedic Churna and Goli, Common Disease Medicines, Hair Growth Medicine, Ayurvedic Powder and Medicinal Herbs, Medicinal Roots, Ayurvedic Herbal Syrups & Tonics, Cooking Spices and Masala.
Who are the key members and board of directors at Atrey Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Minish Shah  | Director | 26-Apr-2013 | Current |
| Naman Shah | Director | 26-Apr-2013 | Current |
Financial Performance of Atrey Pharmaceuticals.
Atrey Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 33.69% decrease. The company also saw a substantial fall in profitability, with a 61.81% decrease in profit. The company's net worth moved up by a moderate rise of 1.64%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Atrey Pharmaceuticals?
Unlock access to Atrey Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Sidbi Creation Date: 15 Mar 2022 | ₹1.77 M | Open |
Sidbi Creation Date: 18 Aug 2020 | ₹3.53 M | Open |
Sidbi Creation Date: 17 Apr 2020 | ₹1.19 M | Open |
How Many Employees Work at Atrey Pharmaceuticals?
Unlock and access historical data on people associated with Atrey Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Atrey Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Atrey Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
